https://www.novonordisk.es/
Somos una compañía global dedicada al cuidado de la salud, fundada en 1923 y con sede a las afueras de Copenhague, Dinamarca. Nuestro propósito es impulsar el...
novo nordiskspain
https://www.novonordisk.com/
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other...
novo nordisk
https://runsignup.com/Race/MD/Elkridge/NovoNordiskKidsChallenge
The Novo Nordisk Kids Challenge is on Monday July 6, 2020 to Wednesday September 30, 2020.
novo nordiskkidschallenge
https://www.fool.com/earnings/call-transcripts/2021/11/03/novo-nordisk-as-nvo-q3-2021-earnings-call-transcri/
NVO earnings call for the period ending October 31, 2021.
earnings call transcriptnovo nordisknvo
https://www.ainvest.com/news/novo-nordisk-100-billion-obesity-market-leader-navigating-pricing-reimbursement-cardiovascular-data-hurdles-2512/
Novo Nordisk: A $100 Billion Obesity Market Leader Navigating Pricing, Reimbursement, and Cardiovascular Data Hurdles
novo nordiskmarket leaderbillionobesitynavigating
https://www.biopharmadive.com/news/novo-nordisk-foundation-makes-green-grant-to-danish-us-university-collabora/562328/
The $27 million grant will fund a five-year program in biopharmaceutical manufacturing, run in partnership by NC State and the Technical University of...
novo nordisk foundationus universitymakesgreengrant
https://www.euractiv.com/news/novo-nordisk-warns-eu-loophole-may-fuel-fake-ozempic-trade-pharmacists-push-back/
Dec 1, 2025 - Drugmakers warn of a 'Wild West' of unauthorised medicines as pharmacists call it a false alarm
novo nordiskwarnseuloopholemay
https://www.openpr.com/news/1371710/insulin-market-2018-with-major-key-players-novo-nordisk-a-s-julphar-gulf-pharmaceutical-industries-sanofi-s-a-biocon-limited-glaxosmithkline-and-wockhardt.html
Press release - Coherent Market Insights - Biotechnology - Insulin Market 2018 With Major Key Players Novo Nordisk A/ S, Julphar Gulf Pharmaceutical...
major keynovo nordiskinsulinmarketplayers
https://www.actionnewsjax.com/news/business/hims-hers-launches/EEDUNBFJRE7ETC6BEMSODRQVQ4/
Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy
novo nordiskhimslauncheswegovyknockoff
https://www.fool.com/investing/2024/03/25/novo-nordisk-and-eli-lilly-may-finally-have-some-r/
Novo Nordisk and Eli Lilly dominate the weight-loss market, but progress from a rising biotech could spell trouble for the pharma giants.
novo nordiskeli lillymayfinallyreal
https://www.zawya.com/en/business/healthcare/novo-nordisk-in-deal-to-produce-weight-loss-drug-in-saudi-xvq1m7f8
Novo Nordisk plans to launch Wegovy in the Saudi Arabian market in 2025
weight loss drugnovo nordiskdealproduce
https://www.prnewswire.com/news-releases/novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults-now-broadly-available-across-america-302652205.html
Average weight loss of ~17% if all patients stayed on treatment* with Wegovy® (semaglutide) tablets 25 mg (~14% regardless of if patients stayed on...
novo nordiskpillfirstoral
https://www.novonordisk.co.th/
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other...
novo nordiskthailand
https://www.manager-magazin.de/unternehmen/pharma/nach-dem-kurssturz-der-rettungsplan-fuer-novo-nordisk-a-a7e0061d-60ca-43ef-ab9b-4f9014bc45fd
Dec 20, 2025 - Dank der Abnehmspritze Wegovy stieg der dänische Pharmakonzern Novo Nordisk fast über Nacht zum wertvollsten Konzern Europas auf. Dann folgte der Absturz....
novo nordiskmanager magazinnachdemder
https://www.pharmaceutical-technology.com/data-insights/lefelsiran-sodium-novo-nordisk-alcohol-dependence-likelihood-of-approval/
Lefelsiran sodium is under clinical development by Novo Nordisk and currently in Phase I for Alcohol Dependence.
novo nordiskalcohol dependencesodiumlikelihood
https://www.benzinga.com/markets/large-cap/26/01/49971430/novo-nordisks-newly-approved-weight-loss-pill-shows-record-prescription-data
U.K. drug regulator approves higher Wegovy dose as Novo Nordisk seeks U.S. and EU clearance. Trial data showed up to 21% average weight loss in adults with...
novo nordiskwegovymakerstocksoaring
https://www.statnews.com/2026/01/14/jpm-2026-day-3-top-stories-sanofi-bms-pfizer-biontech/
Jan 14, 2026 - Day 3 of the JP Morgan Healthcare Conference newsletter has news and updates from Novo Nordisk, Sanofi, Pfizer, Bristol Meyers Squibb, and other companies.
news dayconference highlightsjpmincludenovo
https://www.deccanchronicle.com/world/novo-nordisks-obesity-drug-goes-on-sale-in-china-1839564
Beijing: Novo Nordisk's blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP on Tuesday, as the Asian nation...
novo nordiskobesity druggoessalechina
https://www.boerse-express.com/news/articles/novo-nordisk-aktie-preisdruck-steigt-847241
Der dänische Pharmakonzern Novo Nordisk sieht sich mit Preisdruck in den USA und generischer Konkurrenz in Indien konfrontiert, während die Aktie nach dem...
novo nordiskexpressaktie
https://www.technologynetworks.com/genomics/news/university-of-copenhagen-wins-novo-nordisk-grant-to-build-proteomics-center-212973
The University of Copenhagen in Denmark plans to use a KRO 600 million grant from the Novo Nordisk Foundation to build a protein research center.
novo nordiskuniversitycopenhagenwinsgrant
https://www.fiercebiotech.com/r-d/novo-nordisk-backs-out-of-a-diabetes-deal-zosano
Novo Nordisk has terminated a collaboration deal with Zosano Pharma, walking away from an agreement that would have paired its late-stage diabetes drug with...
novo nordiskbacksdiabetesdeal
https://www.zawya.com/en/world/uk-and-europe/massive-fire-at-danish-pharma-giant-novo-nordisk-oahl57xd
"It's a massive fire. We have about 100 firefighters on site", fire service chief of operations Martin Smith told AFP
novo nordiskmassivefiredanishpharma
https://www.forbespt.com/espanhol-nicolas-villar-assume-a-lideranca-da-novo-nordisk-em-portugal/?doing_wp_cron=1767838752.6801600456237792968750
Nov 3, 2025 - O executivo Nicolas Villar, que fez carreira internacional, acaba de substituir a gestora portuguesa Paula Barriga na liderança da Novo Nordisk Portugal. A...
novo nordiskespanholnicolasvillarassume
https://www.novonordisk.com/content/nncorp/global/en/investors/contact-investor-relations.html
Shareholders and financial analysts should address inquiries concerning Novo Nordisk and its business operations to the Investor Relations Officers.
investor relations teamnovo nordisk
https://www.finder.com/stock-trading/health-stocks/buy-novo-nordisk-as-stock
We explain how to buy Novo Nordisk A/S stock, compare the best stock trading platforms and use a detailed analysis to learn about (NVO).
novo nordiskbuystocknvo
https://www.technologynetworks.com/proteomics/news/novo-nordisk-and-sangamo-biosciences-announce-agreement-203925
Sangamo will provide its ZFP technology for Novo Nordisk to evaluate for use in the field of enhanced protein production.
novo nordisksangamo biosciencesannounceagreementtechnology
https://marketrealist.com/2016/09/novo-nordisk-expects-witness-strong-growth-new-product-launches-future-years/
In addition to its robust drug portfolio, Novo Nordisk boasts a strong research pipeline in the diabetes, hemophilia, obesity, and growth disorder segments.
novo nordisknew productexpectswitnessstrong
https://www.clinicaltrialsarena.com/news/novo-nordisk-announces-positive-results-from-oral-semaglutide-trial/
The PIONEER clinical programme evaluated the effects of the drug on HbA1c and body weight in people with type 2 diabetes.
novo nordiskpositive resultsoral semaglutideannouncestrial
https://fintechzoom.com/stocks/novo-nordisk-nvo/novo-nordisk-stock-increased-3-9/
Explore how Novo Nordisk Stock surged by 3.9% as new biotech collaborations promise innovative treatments for obesity and liver diseases.
novo nordiskstrategic collaborationsstockincreased
https://www.novonordisk.com/content/nncorp/global/en/contact-us/contact-overview.html
Do you need to get in touch with us? See your options here. Reach out to your local Novo Nordisk office or call our corporate headquarters. Tel: +45 4444 8888,...
novo nordiskhelp
https://www.novonordisk.al/
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other...
novo nordiskalbania
https://cpha.com/novonordisk/
Apr 27, 2023 - Novo Nordisk—NovoCare® Resources for you, support for your patients Build knowledge with diabetes education and resources from NovoCare®. Find recipes that...
novo nordiskcaliforniapharmacistsassociation
https://finviz.com/news/283794/jim-cramer-on-novo-nordisk-i-think-theyre-making-a-turn-here
Stock screener for investors and traders, financial visualizations.
jim cramernovo nordiskthinkmaking
https://www.cnbc.com/2025/12/22/fda-approves-first-glp-1-pill-for-obesity-from-novo-nordisk.html
Dec 23, 2025 - The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is racing to launch its own obesity pill.
fdafirstglppillobesity
https://www.novonordisk.ae/
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other...
novo nordiskuae
https://www.freemalaysiatoday.com/category/business/2024/03/08/novo-nordisk-eyes-china-approval-for-weight-loss-drug-wegovy
The obesity treatment is expected to be approved for sale in the largest Asian market this year.
weight loss drugnovo nordiskeyeschinaapproval
https://www.tampafp.com/novo-nordisk-slashes-wegovy-and-ozempic-prices-amid-trump-pressure-and-competition/
Nov 18, 2025 - Novo Nordisk announced Monday that it is significantly cutting the prices of its blockbuster GLP-1 drugs, Wegovy (for weight loss) and Ozempic (for diabetes),
novo nordiskslasheswegovyozempicprices
https://www.novonordisk.iq/
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other...
novo nordiskiraq
https://endpoints.news/novo-nordisks-direct-to-patient-platform-gains-momentum-as-self-pay-sales-rise/
Oct 29, 2025 - Consumers are having an entirely different relationship with how they access weight loss drugs, buying them even if there isn’t insurance coverage. And it's...
novo nordiskdirectpatientplatformgains
https://atom-computing.com/eifo-and-the-novo-nordisk-foundation-acquire-the-worlds-most-powerful-quantum-computer/
Jul 17, 2025 - EIFO and Novo Nordisk Foundation
novo nordisk foundationacquire
https://www.fool.com/investing/2024/06/29/if-these-3-words-are-true-altimmunes-weight-loss-c/
The market for weight loss medicines keeps getting hotter and hotter.
weight losswordstrue
https://novonordiskfonden.dk/projekter/novo-nordisk-foundation-co2-research-center/
Feb 19, 2025 - Atmosfærisk CO2 er en af hovedårsagerne til de menneskeskabte klimaforandringer. Hvis man for alvor skal bremse de globale temperaturstigninger, er det ikke...
novo nordisk foundationresearch centerfonden
https://www.prnewswire.com/news-releases/eleven-therapeutics-announces-research-collaboration-with-novo-nordisk-to-discover-cell-specific-carriers-of-nucleic-acid-therapeutics-301878265.html
/PRNewswire/ -- Eleven Therapeutics, a biotechnology company developing next-generation RNA therapeutics through the mastery of combinatorial chemistry and...
research collaborationnovo nordiskeleventherapeuticsannounces
https://www.cnbc.com/video/2025/12/23/fda-approves-first-ever-glp-1-pill-from-wegovy-maker-novo-nordisk.html
Dec 23, 2025 - CNBC’s Annika Kim Constantino reports on the FDA's approval of the first GLP-1 pill for obesity from Wegovy maker Novo Nordisk.
first everfdaglppillwegovy
https://www.pharmaceutical-technology.com/news/novo-nordisk-job-cut-1300-employees/
Novo Nordisk job cut will involving laying off a total of 1,300 employees by the end of this year as part of its R&D organisation restructuring.
novo nordiskjobcutcoveraround
https://www.teamnovonordisk.com/
Jan 12, 2026 - Meet the world’s first all-diabetes pro cycling team. Our athletes race worldwide to inspire, educate, and empower everyone living with diabetes.
pro cycling teamdiabetestypenovo
https://www.financialexpress.com/market/global-markets/novo-nordisk-rockets-25-in-a-month-but-should-you-buy-the-rally/4109903/
Novo Nordisk shares have surged on the back of its groundbreaking oral Wegovy approval, making it the first company to bring a pill for weight loss to market.
novo nordiskrocketsmonth
https://www.weforum.org/organizations/novo-nordisk-a-s/?article_topic=forum-institutional
The Novo Nordisk Foundation is an independent Danish foundation with corporate interests. Its objectives are twofold: to provide a stable basis for the...
world economic forumnovo nordisk
https://www.cnbc.com/2026/01/16/novo-nordisk-shares-wegovy-obesity-pill-launch.html
Jan 16, 2026 - The early data is a boost to the Danish drugmaker's hopes of winning back more market share from Eli Lilly in the obesity drug space.
novo nordisksharesrisewegovyobesity
https://finviz.com/news/261088/novo-nordisk-vs-amgen-which-healthcare-stock-is-the-smarter-choice
Stock screener for investors and traders, financial visualizations.
novo nordiskvsamgenhealthcarestock
https://www.freemalaysiatoday.com/category/business/2025/08/06/wegovy-maker-novo-nordisk-to-reduce-costs-after-us95bil-stock-loss
Maziar Mike Doustdar will take the helm as CEO tomorrow, with the firm facing tough questions from investors about how it can stay competitive.
novo nordiskreduce costswegovymakerus
https://www.zf.ro/eveniment/iulia-chapuis-novo-nordisk-romania-cred-in-stilul-de-leadership-care-22960735
Sănătatea angajaţilor şi cultura organizaţională nu mai pot fi tratate separat de strategia de business, susţine Iulia Chapuis, people &...
novo nordiskiuliachapuisromaniacred
https://www.globenewswire.com/news-release/2026/02/04/3232199/0/en/Novo-Nordisk-files-annual-report-with-the-SEC.html
Novo Nordisk A/S has filed its Annual Report 2025 on Form 20-F for the financial year 2025 with the US Securities and Exchange Commission...
novo nordiskannual reportfilessec
https://www.today.com/health/news/fda-approves-wegovy-weight-loss-pill-rcna250594
Dec 22, 2025 - The Food and Drug Administration approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.
weight loss pillnovo nordiskfdawegovy
https://www.fool.com/investing/2024/03/10/is-novo-nordisk-a-buy-after-its-new-obesity-candid/
Encouraging results recently pushed the pharma stock up to new heights.
novo nordiskbuynewobesitycandidate
https://www.cnbc.com/2026/01/05/first-glp-1-pill-for-obesity-from-novo-nordisk-launches-in-the-us.html
Jan 5, 2026 - The drug's cash prices are among the lowest on the market, ranging from $149 to $299 per month, depending on the dose.
novo nordiskfirstglppillobesity
https://www.statnews.com/2025/11/05/biotech-news-pfizer-on-novo-metsera-bidding-war/
Nov 5, 2025 - Today's biotech news includes Pfizer's view on the Metsera bidding war, Novo CEO's defense, and another startup licenses from Jiangsu Hengrui
novo nordiskpfizerreadoutnewsletter
https://www.bitpanda.com/nl/koers/stocks/novo-nordisk-novo
Bekijk de actuele koers van Novo Nordisk (ADR) aandelen via Bitpanda. Investeer veilig in aandelen zonder verborgen kosten op ons platform.
novo nordiskadrkoersnvoaandelen
https://www.pharmaceutical-technology.com/news/newsnovo-nordisk-develop-new-haemophilia-treatment-manufacturing-facility-denmark-4569015/
Denmark-based Novo Nordisk has unveiled plans to invest kr1.5bn ($224m) for developing a new haemophilia treatment manufacturing facility in Kalundborg.
novo nordiskmanufacturing facilitydevelopnewhaemophilia
https://www.concertation-novonordisk-chartres.fr/
Concertation Novo Nordisk
novo nordisk
https://www.law360.com/healthcare-authority/cases/6892442f0a85a484bb78c61f?article_sidebar=1
Parties, docket activity and news coverage of federal case Novo Nordisk A/S et al v. Mochi Health Corp. et al, case number 5:25-cv-06563, from California...
novo nordisket almochihealthcorp
https://www.novonordisk.com/investors/capital-markets-day-2024.html
Watch Capital Markets Day 2024 webcasts and get a detailed view into our executive management team and the performance and strategies of Novo Nordisk.
capital markets daynovo nordiskwebcastspresentations
https://www.pharmaceutical-technology.com/news/2seventy-bio-completes-40m-haemophilia-a-program-deal-with-novo-nordisk/
US-based 2seventy bio has completed an asset purchase agreement (APA) to divest its haemophilia A candidate to Novo Nordisk.
biocompleteshaemophiliaprogramdeal
https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults-302648344.html
Average weight loss of ~17% if all patients stayed on treatment* with Wegovy® (semaglutide) tablets 25 mg (~14% regardless of if patients stayed on...
novo nordiskfdapillfirst
https://www.placera.se/nyheter/handelsbanken-salj-novo-nordisk--kop-investors-bjasse-2025-11-27
Nov 27, 2025 - Handelsbanken sänker den danska läkemedelsjätten till sälj och upprepar köp för Investors verkstadsbolag.
novo nordiskhandelsbankeninvestorsse
https://www.manager-magazin.de/unternehmen/pharma/novo-nordisk-einstellungsstopp-als-reaktion-auf-kostendruck-und-konkurrenz-a-22cf6160-2aee-4715-b50d-dc3e15d7f55d
Aug 20, 2025 - Wachsender Kostendruck, sinkende Prognosen und Konkurrenz durch Rivalen wie Eli Lilly: Pharmakonzern Novo Nordisk, einst das wertvollste Unternehmen Europas,...
novo nordiskalsreaktionaufund
https://www.fiercebiotech.com/medical-devices/ibm-novo-nordisk-team-to-seek-new-diabetes-treatments-through-cloud
Danish pharma giant Novo Nordisk is teaming with IBM's Watson Health division in a combo the two companies hope will lead to a better understanding, and...
novo nordiskdiabetes treatmentsibmteamseek
https://www.ainvest.com/news/novo-nordisk-strategic-position-glp-1-market-stock-volatility-2601/
Novo Nordisk's Strategic Position in the GLP-1 Market Amid Stock Volatility
novo nordiskstrategicpositionglpmarket
https://www.cmcmarkets.com/en-gb/opto/novo-nordisknvidia
Novo Nordisk Fonden, the enterprise foundation behind the pharma giant, is to collaborate with Nvidia on a Danish supercomputer.
novo nordisknvidia
https://www.home.saxo/en-mena/content/articles/equities/novo-nordisk-2026-04022026
Exploring the market reaction to Novo Nordisk's 2026 revenue guidance cut and the impact of US prescription data on the weight-loss market.
new realitynovo nordisksaxo bank
https://www.uschamber.com/cases/property-rights/novo-nordisk-inc-v-kennedy
U.S. Chamber files amicus brief urging Supreme Court to grant petition for certiorari to review Third Circuit decision rejecting constitutional challenge to...
novo nordiskinckennedyuchamber
https://www.nasdaq.com/market-activity/stocks/nonof/historical
Find the latest historical data for Novo Nordisk - Class B (NONOF) at Nasdaq.com. View historical data in a monthly, bi-annual, or yearly format.
novo nordiskclass bhistorical datanasdaq
https://www.statnews.com/2025/11/24/novo-nordisk-semaglutide-wegovy-ozempic-alzheimers-trial-failure/
Nov 24, 2025 - The drug, the key ingredient in Ozempic and Wegovy, did not outperform placebo in two trials, studies that had been considered long shots.
novo nordisksemaglutidefailsslowalzheimer
https://www.businessgreen.com/news/3074864/solar-powered-pills-novo-nordisk-meets-renewables-target
Investment in a vast solar installation will enable Danish pharmaceutical firm Novo Nordisk to meet its 2020 renewable energy goals.
solar powerednovo nordiskpillsmeetsrenewables
https://www.pharmaceutical-technology.com/news/strong-wegovy-revenue-growth-for-novo-nordisk-but-shares-dip/
Sales of the GLP-1RA hit $2.5bn in Q3, a 79% increase over the same period last year.
revenue growthnovo nordiskstrongwegovyshares
https://www.novonordisk.jo/
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other...
novo nordiskjordan
https://www.pymnts.com/cpi-posts/eli-lilly-and-novo-nordisk-accused-of-blocking-access-to-lower-cost-weight-loss-drugs/
Jan 15, 2026 - A compounding pharmacy filed a federal lawsuit accusing Eli Lilly and Novo Nordisk of using their market power to restrict access to drugs.
eli lillynovo nordiskaccusedblockingaccess
https://cryptorank.io/news/feed/54d77-why-novo-nordisk-cut-prices-of-its-weight-loss-drug-in-india-5-key-points
Novo Nordisk has cut the price of its blockbuster weight-loss drug Wegovy by up to 33% in India, a Reuters report said on Tuesday. The move aimed at expanding
weight loss drugnovo nordiskslashedprices
https://www.news-medical.net/news/20100303/Novo-Nordisk-awarded-contract-by-VA-as-primary-source-provider-of-insulin.aspx
Novo Nordisk, a global healthcare company and leader in diabetes care, announced it has been awarded a contract by the U.S. Department of Veterans Affairs as...
novo nordiskprimary sourceawardedcontractva
https://www.ainvest.com/news/eli-lilly-oral-obesity-pill-catch-outperform-novo-nordisk-2026-2601/
Eli Lilly's Oral Obesity Pill: Can It Catch Up and Outperform Novo Nordisk in 2026?
eli lillyoralobesitypillcatch
https://marketrealist.com/2016/09/novo-nordisk-expected-witness-strong-growth-insulin-segment-2016/
Insulin sales volumes sold across the world have grown at a compounded average growth rate (or CAGR) of 4.1% from May 2011 to May 2016.
novo nordiskexpectedseestronggrowth
https://www.news-medical.net/news/20110119/Novo-Nordisks-new-insulin-pen-for-children-receives-2010-GOOD-DESIGN-Award.aspx
A 2010 GOOD DESIGN Award has been awarded to Novo Nordisk for NovoPen Echo, the latest innovation in pen development - designed specifically with the needs of...
novo nordiskinsulin pennewchildrenreceives
https://www.marketscreener.com/news/novo-nordisk-gets-a-buy-rating-from-goldman-sachs-ce7e58d2d18ef320
In a research note published by James Quigley, Goldman Sachs advises its customers to buy the stock. The target price has been lifted and is now set at DKK 436...
novo nordiskgoldman sachsgetsbuyrating